Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001193125-25-107499
Filing Date
2025-04-30
Accepted
2025-04-30 16:41:29
Documents
4
Period of Report
2025-04-30

Document Format Files

Seq Description Document Type Size
1 PRE 14A d896191dpre14a.htm PRE 14A 245314
2 GRAPHIC g896191g00n20.jpg GRAPHIC 133129
3 GRAPHIC g896191g00n21.jpg GRAPHIC 119754
4 GRAPHIC g896191g53p02.jpg GRAPHIC 48363
  Complete submission text file 0001193125-25-107499.txt   652015
Mailing Address 260 SHERIDAN AVENUE SUITE 400 PALO ALTO CA 94306
Business Address 260 SHERIDAN AVENUE SUITE 400 PALO ALTO CA 94306 650-800-6676
Vincerx Pharma, Inc. (Filer) CIK: 0001796129 (see all company filings)

EIN.: 833197402 | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-39244 | Film No.: 25896181
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)